In the latest trading session, 83.1 million Salarius Pharmaceuticals Inc (NASDAQ:SLRX) shares changed hands as the company’s beta touched 0.82. With the company’s most recent per share price at $5.33 changing hands around $3.76 or 240.58% at last look, the market valuation stands at $7.70M. SLRX’s current price is a discount, trading about -35.08% off its 52-week high of $7.20. The share price had its 52-week low at $1.22, which suggests the last value was 77.11% up since then. When we look at Salarius Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 0.11 million shares, with the 3-month average coming to 346.99K.
Salarius Pharmaceuticals Inc (NASDAQ:SLRX) trade information
Instantly SLRX is in green as seen in intraday trades today. With action 213.53%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 189.67%, with the 5-day performance at 213.53% in the green. However, in the 30-day time frame, Salarius Pharmaceuticals Inc (NASDAQ:SLRX) is 229.01% up. Looking at the short shares, we see there were 65040.0 shares sold at short interest cover period of 0.08 days.
Salarius Pharmaceuticals Inc (SLRX) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 64.97%.
SLRX Dividends
Salarius Pharmaceuticals Inc is expected to release its next quarterly earnings report in February.
Salarius Pharmaceuticals Inc (NASDAQ:SLRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.52% of Salarius Pharmaceuticals Inc shares while 0.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 0.37%.
Among Mutual Funds, the top two as of Nov 30, 2024 were Fidelity Extended Market Index Fund and Listed Funds Tr-Horizon Kinetics Medical ETF. With 5.74 shares estimated at $32190.0 under it, the former controlled 0.40% of total outstanding shares. On the other hand, Listed Funds Tr-Horizon Kinetics Medical ETF held about 0.26% of the shares, roughly 3.72 shares worth around $20886.0.
